Canopy Growth reports revenue up via domestic and international sales
Ontario-based Canopy Growth Corporation (TSX: WEED) announced Q3 fiscal 2018 results, including record revenue and strong growth in Canada and Germany.
Among the results:
- Revenue of $21 million, up 23%
- Oil sales, including gel caps, accounted for 23% of revenue
- Active patients increased 10% to 69,000
- Kilograms sold rose 15% to 2,330kgs
- Average selling price per gram rose 4% to $8.30
- Cost per gram dropped 18%
- Record Germany quarterly sales of $1 million, all from domestic Canadian production
- Average price in Germany of $12.61 per gram
- Year-over-year registered patient growth of 138% and revenue growth of 123%
- Multi-year supply agreements with four provinces totaling 25,000 kgs per year
- Raised $245 million in deal with Constellation Brands
- Raised $201 million in bought deal financing
“The Company’s record revenues in the quarter were driven by a significant increase in domestic sales across all product formats as well as sales in the German medical market…” said Bruce Linton, Chairman & CEO. “Success…will depend not only on capacity, but on strong execution and securing supply agreements with the provinces. With millions of square feet of production expansion underway across the country and around the world…we will ensure a sufficient and timely flow of supply….,” he added.
Canopy Growth reports revenue up via domestic and international sales
About Cannin Investment Group: Your Pot Stocks Experts
Cannin is your trusted resource for pot stocks. Our global team of experts evaluates all emerging pot stock investing opportunities. We aggregate hundreds of hours of research and provide tips on the best pot stock investments for 2020.
Use Cannin as your resource for:
- Cannabis and hemp investing news
- Featured cannabis and hemp company analysis
- Comprehensive cannabis and hemp stock reports
Is it too late to invest in pot stocks? No! This is the perfect time to invest.
Market analysts expect the legal cannabis industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in pot stocks is now. Are you looking to buy stock in pot companies for 2020? Interested in emerging penny pot stocks? Looking for the best Canadian pot stocks to invest in? We can help.
Are you interested in pot stocks like Curaleaf, Trulieve, Aurora Cannabis, or Canopy Growth?
Predict price movements of pot stocks several hours in advance with our proprietary algorithmic stock trading software.
- +25% Gains in 2020
- +49.8% Gains in 2019
- 108% Backtested since 2012
We’re so confident you’ll love our algotrading pot stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.
Profit from the best pot stocks – we’ll show you how at cannin.com.
Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Best Hemp Stocks to Invest In